UBS
-
The underperformance of China Aoyuan Property Group’s bond on Thursday cast a shadow over new issues from Yuzhou Properties Co and Fantasia Holdings Group Co, with pretty muted responses for both deals.
-
Nordic Capital has sold the last of its stake in ConvaTec, the UK medical supplies manufacturer that floated on the London Stock Exchange (LSE) in 2016, ending a decade long investment.
-
CEVA Logistics, the freight management and contract logistics company, priced its IPO on the SIX Swiss Exchange at the bottom of the range on Thursday.
-
China Aoyuan Property Group’s $200m bond dropped sharply in the secondary market on Thursday as global markets wreaked havoc on the company’s notes.
-
UBS has submitted an application to the China Securities Regulatory Commission to bump up the stake in its China joint venture to 51%, becoming the first international bank to take advantage of China’s recent move to open up its financial sector.
-
China Aoyuan Property Group, Hydoo International Holding and Indonesia’s Federal International Finance wasted no time in hitting the bond market on Wednesday after the Labour Day holiday.
-
Huya, a live streaming platform backed by YY and Tencent, has started bookbuilding for its up to $180m IPO on the New York Stock Exchange.
-
CEVA Logistics, the freight management and contract logistics company listing in Switzerland, has narrowed the price range on its IPO. The books are covered in excess of the deal size in the bottom half of the range.
-
Ping An Healthcare and Technology priced its HK$8.8bn ($1.1bn) IPO at the top of guidance after a flood of demand from local and international investors.
-
Indonesian property company Bumi Serpong Damai returned to the debt market on Monday for a quick $50m tap to its $250m 7.25% 2021 bond that was sold last week.
-
Sweeping US tax code reforms could have a big impact on banks with intermediate holding companies in the US, perhaps forcing them to fund from the IHCs directly, rather than from their parent companies.
-
Polyphor, the Swiss pharmaceutical company, began bookbuilding on Friday for its IPO on the SIX Swiss Exchange, with a price range that values it at up to Sfr401m.